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Abstract 
 
Background: The validity of borderline personality disorder (BPD) has been a topic of much controversy in psychiatry. 
Over the last two decades, a wealth of empirical work has challenged long-held concerns regarding the validity of adolescent 
BPD. However, this research has been conducted within a traditional approach to psychiatric nosology. 
Objective: In this article, we aim to evaluate the validity of adolescent BPD as guided by both the Robins and Guze criteria 
for the validity of psychiatric constructs and the new National Institute of Mental Health Research Domain Criteria (NIMH 
RDoC). 
Method: We used the five principles of the Robins and Guze approach to evaluate selected research from our own and 
other groups regarding the validity of adolescent BPD. These principles include clinical description studies, laboratory 
studies, studies that delimitate the disorder from other related syndromes, follow-up studies, and family studies. 
Results: Within the Robins and Guze criteria framework, evidence to date supports the validity of adolescent BPD to some 
extent. However, limitations of the research about the construct validity of adolescent BPD have also been identified, most 
notably regarding the delimitation of adolescent BPD from other disorders as well as a lack of longitudinal and family 
studies. 
Conclusions: Given these limitations and the limitations of the Robins and Guze approach to psychiatric nosology, we 
recommend exploring the potential of the National Institute of Mental Health Research Domain Criteria as a complement 
to previous work. 
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Determining the Validity of a Psychiatric 
Disorder 
In 2008, Chanen and McCutcheon published a 
paper entitled, “Personality disorder in adolescence: 
the diagnosis that dare not speak its name” (1). This 
title speaks to the concerns that were present as 
recently as six years ago regarding the validity of 
personality disorder (PD) in adolescents, specifically 
borderline personality disorder (BPD). Indeed, at 
that time, the majority of British psychiatrists (63%) 
considered the diagnosis of adolescent PD to be 
invalid (2), and many clinicians still appear to be 
uncomfortable diagnosing PD in adolescents (3). 
Hesitations regarding diagnosing this disorder in 
youth are based on sound concerns. Many believe 
that a BPD diagnosis during adolescence engenders 
stigma (4); that personality is inherently unstable 
during adolescence (5,6); and that the clear 
demarcation of pathological borderline traits from 
typical youth behavior (e.g., impulsivity, moodiness) 
is elusive (7). Specifically, adolescents undergo 
dramatic bodily changes, significant increases in the 
intensity of affective and emotional drives, and deep 
reorganization of the self in the context of peer-
directed norms and interactions in addition to 
pressures toward autonomy and the assumption of 
adult roles (8,9). Further complicating the 
demarcation of BPD from normal adolescence is 
the fact that some of the behaviors that characterize 
adolescent BPD (e.g., self-harm, substance abuse, 
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sexual risk-taking behavior) commonly occur during 
adolescence (10-12). These normative develop-
mental changes resemble BPD to some extent and 
add to concerns regarding the validity of a BPD 
diagnosis in this age group. 
But how do we determine the validity of a 
psychiatric disorder? In reaction to a lack of clarity 
surrounding scientific procedures to address this 
question, in 1970, Robins and Guze (13) proposed a 
set of five principles that have since guided research 
regarding the nosology of psychiatric disorder. In 
contrast with heavy reliance on a priori 
hypothesized diagnostic criteria, which was a 
common part of early psychiatric disorder 
classification, the Robins and Guze method ensured 
that only through a series of systematically 
conducted and empirically sound studies can the 
suggestion that a particular diagnostic entity exists 
be substantiated. It is through this framework that 
much of the work over the past few decades 
examining BPD in both adults and adolescents has 
been concentrated. Although they were published 
more than 40 years ago, the Robins and Guze 
criteria are still considered the gold standard 
approach for establishing the diagnostic validity of 
psychiatric disorders. 
The Robins and Guze principles reflect the 
inclusion of five types of research studies, each of 
which is aimed at capturing a specific and separate 
component of a disorder’s nosology: 
 
1) Clinical description studies, which aim to establish a 
coherent clinical picture of the disorder. Studies in this 
category must demonstrate that the disorder has a 
particular and consistent pattern of symptoms and 
that these symptoms co-occur. Moreover, important 
non-psychopathological features that are common 
or prototypical of clinical presentations of the 
disorder must also be identified. These may include 
factors such as age, sex, and age of onset, among 
others. 
2) Laboratory studies, which focus on identifying 
neurobiological and physiological substrates of the disorder. 
Laboratory tests provide an important complement 
to clinical descriptive studies, especially when they 
confirm clinical observations. 
3) Studies that delimitate the disorder from other related 
syndromes. These studies pinpoint a disorder’s 
uniqueness relative to other psychiatric disorders 
with similar phenotypic presentations by 
establishing rates of co-occurrence with related 
disorders and supporting the discriminant validity of 
the construct. 
4) Follow-up studies that identify a prototypical course and 
outcome of the symptoms. For example, demonstrating 
that individuals who were first identified with the 
disorder in baseline assessments present with the 
same disorder (as opposed to a different psychiatric 
disorder) as identified by later assessments provides 
evidence for the original diagnostic criteria used at 
baseline. 
5) Family studies that identify a genetic basis of the 
biological phenomena associated with the disorder. 
Demonstrating that the disorder displays heritability 
provides evidence for distinct psychopathological 
processes related to its phenomenology. 
 
Over the past two decades, much of the work 
examining the validity of BPD in adolescents, 
including our own work, has been guided by these 
principles. Although these guidelines have been 
crucial for advancing psychiatric research in general, 
the system is limited in its focus on the behavioral 
phenotype. In other words, it relies solely on 
observable behavior when describing psychiatric 
disorder rather than understanding the disorder in 
terms of its underlying processes and mechanisms. 
Analogizing from the animal world, after observing 
the physical features of a hippopotamus, most 
would agree that the animal resembles the pig family 
and thus believe that the pig is the closest living 
relative of the hippopotamus. However, zoologists 
tell us that the closest living relative of the 
hippopotamus is the whale. Therefore, relying solely 
on the physical features of a phenomenon when 
evaluating its validity can cause obvious problems. 
In the case of psychiatric diagnosis, we deal with 
two specific problems that are characteristic of the 
Diagnostic and Statistical Manual of Mental Disorders 
(DSM)-based categorical and polythetic behavioral 
phenotype. First, psychiatric diagnosis is based on 
clinical observation and patients’ phenomenological 
symptom self-reports. Unlike other medical 
disorders, for which objective diagnostic tests are 
used, we depend on patients’ perceptions of their 
problems and our own (sometimes biased) clinical 
observations. This is particularly problematic in the 
case of PD, because self-reported attributes cannot 
capture the dynamic processes that give rise to the 
discrepancies between self-identified traits and the 
behavioral manifestations that are typically 
characteristic of PDs (14). Second, this implies that 
psychiatric conditions are described in terms of 
polythetic and dichotomous (categorical) diagnoses. 
This means that patients can present with only a 
portion of the criteria that define a disorder and will 
receive a certain diagnosis as long as they have met 
the predetermined symptom threshold (15). 
The reliance on polythetic and dichotomous 
(categorical) diagnoses at the level of the behavioral 
phenotype alone has led to concerns about the 
validity of the nosological system – most notably 
the problem that the use of the system results in 
high rates of comorbidity among disorders, over-
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reliance on disorder “not-otherwise-specified” or 
deferred diagnosis, and lack of diagnostic stability 
(15). Although there is much evidence in support of 
the DSM-based diagnostic system, some have 
expressed concerns that this system does not “carve 
nature closely at its joints” (16) and thus may have 
impeded the use of advances in genomics, 
pathophysiology, and behavioral science to aid in 
the diagnosis and treatment of psychiatric disorders 
(17). To address these limitations, the National 
Institute of Mental Health (NIMH) proposed the 
Research Domain Criteria (RDoC;18) in 2011 to 
implement Strategy 1.4 of the National Institute of 
Mental Health Strategic Plan (19). By following this 
initiative, psychiatry would depart from its 
categorical classification system of mental disorders 
to “develop new ways of classifying mental 
disorders based on dimensions of observable and 
neurobiological measures” (18). In this article, we 
evaluate the validity of BPD in adolescents 
according to both the traditional Robins and Guze 
criteria and the newly formulated RDoC. We will 
focus on work emanating from our own laboratory 
as well as from other laboratories. We begin by 
discussing research organized within the framework 
of the five Robins and Guze criteria, and we then 
evaluate the state of the science involving 
adolescent BPD against these criteria. We then 
discuss the RDoC principles and map directions for 
future research. 
 
Clinical Description 
Categorical Diagnosis 
Robins and Guze’s first principle states that, for a 
disorder to be valid, its criterion set must constitute 
a coherent combination of traits and symptoms that 
“hang together” (13). Statistically operationalized, 
this principle requires that a single common factor 
adequately accounts for covariation among the 
criteria. Studies of adults (20-24) and adolescents 
(25) have factor analyzed the nine DSM borderline 
personality criteria and found evidence for a 
unidimensional factor structure of BPD. With this 
in mind, we used an item response theory (IRT) 
approach to examine DSM-IV BPD criteria in a 
large community sample of young adolescents from 
the United Kingdom (N = 6339; Mage = 11.75 years; 
51.55% girls; 26). The use of IRT in this regard had 
several important advantages. First, because IRT is a 
latent trait approach, it allows for the examination 
of the underlying factor structure of the BPD 
criteria. Second, it addresses important questions 
surrounding DSM-IV BPD criterion functioning. 
This process included examining the extent to 
which a particular BPD criterion discriminated 
among adolescents with regard to their standing 
along the continuum of BPD liability and whether 
certain criteria discriminate better than others. 
Third, it specifies the threshold of endorsement of a 
criterion along the latent continuum of BPD liability 
to determine whether certain criteria are more 
difficult to endorse than others. Lastly, IRT allows 
for the examination of differences in the 
performance of BPD criteria across gender to 
determine whether the BPD criteria are useful for 
both boys and girls. 
In our study, BPD was assessed via the Childhood 
Interview for DSM-IV Borderline Personality 
Disorder (CI-BPD; 27). Results demonstrated that a 
single underlying dimension adequately accounted 
for covariation among the BPD criteria, which lends 
support to the unidimensionality of the BPD 
construct. These findings were consistent with 
studies from the adult literature (20-24) and with 
those of one study that used an adolescent sample 
(25). In addition, items demonstrated good 
discrimination and difficulty parameters. The most 
difficult items included abandonment fears and 
suicidal behavior; this finding converges with 
research in adults that has demonstrated that 
abandonment fears are the least commonly 
exhibited BPD symptom (22,28) and that suicidal 
behaviors are uncommon among young children 
(29). With regard to measurement equivalence 
across gender, although five criteria demonstrated 
differential item functioning, this balanced out at 
the level of the total set of the nine DSM-IV BPD 
criteria, which suggests that the use of the full nine 
criteria is psychometrically valid and advisable. 
Taken together, findings from this study provide 
evidence that the DSM criteria constitute a coherent 
combination of traits and symptoms, even in 
preadolescent and young adolescent youth, for 
whom the empirical base is less developed. 
It is important to establish that a particular 
construct is valid across multiple samples so that it 
can be generalized to the population at large. The 
aforementioned study (26) demonstrated that the 
CI-BPD criteria were most discriminating at the 
highest level of underlying borderline personality 
pathology liability; this finding was not surprising 
given the community-based sample used. It cannot 
be assumed, however, that these criteria function 
similarly in a clinical setting and represent a valid 
approximation of the borderline personality 
pathology construct in clinical populations. Rather, 
there is a possibility that the aforementioned 
community sample findings capture psycho-
pathology or distress in general rather than BPD 
psychopathology in particular. Thus, we revisited 
this question again with a sample of 190 inpatients 
(Mage= 15.39; 9% female; 33% meeting criteria for 
BPD; 30). We used a confirmatory factor analytic 
approach to examine the internal factor structure of 
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the nine CI-BPD items. The internal consistency 
(Cronbach’s alpha = .80), the inter-rater reliability 
(kappa = .89), the convergent validity (with a 
clinician diagnosis kappa of .34 and a p-value of 
<.001, which indicates “fair agreement”), and the 
concurrent validity were examined and empirically 
supported as indicated by associations in the 
expected directions with self-report measures of 
BPD traits, internalizing and externalizing 
pathology, and rates of self-harm and emotional 
dysregulation. Although we did not directly 
compare different models of underlying factor 
structures with one another, confirmatory factor 
analytic results supported a unidimensional factor 
structure for CI-BPD, which indicated that the 
DSM-IV criteria on which the CI-BPD is based 
constitute a coherent combination of traits and 
symptoms, even among adolescents. This study was 
the largest inpatient study to examine the 
psychometric properties of this measure among 
inpatient adolescents. 
Factor analysis of the nine criteria in the absence 
of other PD criteria only narrowly establishes the 
unidimensionality of the construct, which highlights 
an important limitation of the previously mentioned 
research. A more stringent test of unidimensionality 
would involve the factor analysis of the BPD 
criteria alongside Axis I or PD criteria. However, no 
work of this nature has been conducted with 
adolescents, and the results of adult studies are 
mixed. In a minority of studies, the DSM structure 
of PD (ten discrete disorders, including BPD) has 
been supported (31-34). Most studies have failed to 
support the DSM’s putative structure for PD (35-
38), which suggests that the unidimensional factor 
structure of BPD may disintegrate after factor 
analysis involving other PDs. Recently there has 
been a growing interest in considering models that 
evaluate general factors that account for common 
variance among PDs as well as unique sources of 
variance that may represent more specific forms of 
personality pathology. From a factor-analytic 
perspective, this hypothesis can be tested with what 
is termed a bifactor model. This type of model allows 
PD criteria to load on a large general factor that 
encapsulates the dysfunction shared across PDs, 
with additional circumscribed factors that capture 
the unique domains of impairment (39,40). To truly 
clarify whether DSM criteria hang together, factor 
analysis studies of this kind must be undertaken in 
adult and adolescent samples. 
 
Dimensional Self-Report Ratings 
Although support for BPD as measured by clinical 
interview (e.g., with the CI-BPD) is important, 
examining dimensional BPD traits is equally 
important, especially in the context of DSM-5 
Section III. Taking a dimensional approach to 
personality pathology assumes an individual 
difference perspective in which PD pathology is 
evaluated through quantitative models developed 
from observable traits and symptoms. This allows 
for a data-driven approach that involves the data 
delineating the constructs. It also allows for a fine-
grained description of personality pathology rather 
than lumping symptoms in predetermined 
categorical diagnoses. Finally, as demonstrated in 
Section III of the DSM-5, it allows for a hybrid 
model of personality pathology whereby general 
personality pathology is captured by Criterion A 
(dysfunction in self- and other-relatedness) and in 
which specific disorders and traits are captured by 
Criterion B. These advantages are amplified in the 
context of BPD in adolescents. Specifically, 
dimensional measures are crucial for assessing BPD 
in youth precisely because of the concerns 
expressed earlier about categorical diagnosis during 
youth. As compared with categorical approaches, 
dimensional models may better account for the 
developmental variability and heterogeneity 
common among adolescents and identify subclinical 
levels of BPD for early intervention (41). These 
models also allow for the elucidation of heterotypic 
or homotypic continuity of the disorder (i.e., the 
relationship between BPD at one point in time with 
continued dysfunction at a later point), either 
through BPD pathology or a different form of 
pathology. Finally, in contrast with semi-structured 
interviews, which often are expensive and time-
consuming to administer, self-report measures are 
relatively quick and inexpensive to administer, and 
they allow the evaluator to assess a wide range of 
behaviors and symptomatology in a short amount 
of time. 
With the use of the Borderline Personality 
Features Scale for Children (BPFSC; 6) and an IRT 
approach, we examined the factor structure of trait-
based BPD in a community sample of 881 
adolescents between the ages of 13 and 17 years 
(55.9% female; 42). Given the putative factor 
structure of the BPFSC (6), we evaluated a bifactor 
model in which all items were allowed to load onto 
one general factor and in which respective items 
were allowed to load onto four specific factors: 
negative relationships, affective instability, self-
harm, and identity problems. Results did not 
support a bifactor model; the 24 BPFSC items did 
not load onto a general borderline factor or onto 
predicted subfactors. Importantly, strong evidence 
for local dependence between items (the fact that 
two or more items are more highly correlated with 
one another than with the underlying latent trait) 
was exhibited, which suggests item redundancy. We 
therefore removed 13 items to create a shortened 
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version of the BPFSC (BPFSC-11) and tested the 
factor structure of this truncated measure. With 
poorly functioning items removed, a unidimensional 
factor structure emerged. Moreover, when we tested 
the construct validity of the BPFSC-11 in a sample 
of 371 inpatient adolescents, it showed equivalence 
when compared with the longer version of the 
BPFSC, including criterion validity against the 
interview-based assessment of BPD (i.e., the CI-
BPD). 
Further support for the construct validity of trait-
based conceptualizations of BPD symptomatology 
during adolescence was provided in a study of 171 
boys between the ages of eight and 18 years who 
were recruited from the community (43). In this 
study, the cross-informant concordance between 
parent- and self-reported borderline personality 
features using the BPFSC and a newly developed 
parent version of the measure (BPFSP) was 
examined. Results demonstrated modest but 
significant concordance between parent- and self-
report ratings, and this was consistent with findings 
from other psychiatric constructs in child psychiatry 
(44). Borderline features were robustly associated 
with total psychopathology problems as measured 
by the Youth Self-Report and Child Behavior 
Checklist (45) as well as by specific DSM-oriented 
scales. Specifically, boys with high scores on the 
BPFSC had up to six times the relative risk for 
overall psychopathology and up to five times greater 
risk as indicated by relative risk for specific 
psychopathology, including anxiety disorder (4.99), 
conduct disorder (4.59), attention-deficit/ 
hyperactivity disorder (3.88), affective disorder 
(2.86), somatic disorder (2.65), and oppositional 
defiant disorder (2.22). Similarly, boys whose 
parent-reports placed them in a high-BPD trait 
group had up to nine times greater risk for 
externalizing disorders: conduct disorder (8.97), 
oppositional defiant disorder (3.67), and mood 
dysregulation (affective disorder [2.75]). 
In another study involving the BPFSC, we 
examined the performance of parent- and self-
report BPFS tools for detecting the diagnosis of 
BPD in 51 adolescent inpatients between the ages 
of 12 and 18 years (46). This study made use of 
receiver operating characteristic analyses, which 
provide receiver operating characteristic curves or 
the plot of the true-positive rate (sensitivity) against 
the false-positive rate (1-specificity) on a graph. The 
area under the curve (AUC) provides an indicator of 
accuracy. Receiver operating characteristic analysis 
was an advantageous approach in this study, 
because it allowed for the direct comparison of the 
relative performances of the BPSFC and BPFSP for 
predicting a CI-BPD diagnosis. Results 
demonstrated that the BPFSC had high diagnostic 
accuracy (AUC = .93) for discriminating adolescents 
with a CI-BPD diagnosis, and the parent-reported 
version had moderate accuracy (AUC = .80; 
sensitivity = .73; specificity = .72). When comparing 
the measures directly, scores from the BPFSC 
discriminated significantly better than did scores 
from the BPFSP. Concordance between parent and 
child reports was also significant. This study was 
important in that it provided preliminary support 
for the relative advantage of self-report over parent-
report for the assessment of borderline traits during 
adolescence. Given that BPD is suggested to be a 
confluence of internalizing and externalizing 
psychopathology (47,48) and given that research has 
shown self-report to be more valid for internalizing 
disorders during adolescence (whereas parent- or 
teacher-report may be more useful for externalizing 
problems [49]), we suggest that the superior 
performance demonstrated by the self-report 
BPFSC in our studies may be driven by the 
internalizing features of BPD. 
 
Screening Measures 
If BPD assessment is to be routinely included in 
general adolescent assessment services, valid 
assessment tools for this purpose must be available. 
Although the BPFSC-11 would perform well, the 
McLean Screening Instrument for Borderline 
Personality Disorder (MSI-BPD; 50), which was 
originally developed for adults, is another 
alternative. The MSI-BPD is a 10-item self-report 
yes/no measure that provides a brief screening 
assessment of the number of BPD criteria met. It 
was designed specifically with low-resource settings 
in mind, where a quick and economical assessment 
of BPD is necessary for potential inclusion in a 
research study or for follow-up clinical assessment. 
We examined the MSI-BPD’s ability to accurately 
identify adolescents with BPD using the CI-BPD 
and the BPFSC in a sample of 118 inpatients 
recruited from a facility that serves an indigent 
population (Mage = 14.64; 64.4% female) (51). At the 
bivariate level, results demonstrated that the MSI-
BPD was significantly related to both the CI-BPD 
and the BPFSC, although the correlations were of 
moderate magnitude. Similar to results from a study 
conducted in a child and adolescent sample (52) as 
well as in a community sample of adult women (53), 
the MSI-BPD demonstrated moderate diagnostic 
efficiency when predicting the CI-BPD diagnosis, 
with sensitivity (Sn) and specificity (Sp) values of .71 
and .65, respectively, and diagnostic accuracy of .73. 
This study also established an MSI-BPD adolescent-
specific cutoff score of 5.5, whereas the previously 
established cutoff score of 7 rendered in the adult 
sample (53) lowered sensitivity substantially in our 
sample (Sn = 48 and Sp = .83). 
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Summary 
The psychometric work involving at least three 
measures of BPD discussed here provides some 
evidence in support of the borderline construct in 
youth. Collectively, this work suggests that a 
coherent clinical picture of the disorder can be 
described and that a particular and consistent 
pattern of symptoms co-occur even when they are 
assessed using different measures. Moreover, our 
work and the work of others suggest that important 
non-psychopathological features (like those 
captured by prevalence studies) are common or 
prototypical of the clinical presentations of the 
disorder in adolescents. For example, the percentage 
of adolescent inpatients meeting the diagnostic 
criteria of the CI-BPD in our work mirrors that of 
other studies in adolescent inpatient settings that 
report BPD diagnostic prevalence rates of 33% to 
53% (54-56). 
However, it is also clear that further work is 
needed regarding the underlying factor structure of 
PD in adolescents in general and in BPD in 
particular. There is a critical need for evaluating 
more complex bifactor models in adolescent PD for 
both categorical symptom and dimensional trait 
approaches to establish whether a coherent 
syndrome is present in adolescents. In other words, 
to firmly support the unidimensionality of a 
construct, all psychopathology (including all PDs) 
must be considered. In the case of adolescent PD, 
this agenda is complicated by the fact that few 
DSM-based measures of other PDs have been 
developed for adolescents. Although the CI-BPD 
and BPFSC were developed for children and 
adolescents specifically, there are no 
developmentally sensitive counterparts available to 
assess all DSM-II–based PDs. This is necessary to 
move DSM-based diagnostic work forward. 
For trait-based approaches to PD assessment in 
adolescents, the picture is less bleak. There are 
several adolescent trait-based instruments, including 
the Minnesota Multiphasic Personality Inventory – 
Adolescent version (57), which is a 478-item 
true/false self-report inventory designed to assess 
the social, emotional, and behavioral functioning of 
adolescents between the ages of 14 and 18 years 
that has been examined in one study of adolescent 
BPD (58); the Dimensional Personality Symptom 
Item Pool (59), which is a 172-item measure 
structured to assess 27 maladaptive personality 
facets that are hierarchically organized into four 
broad personality dimensions (disagreeableness, 
emotional instability, introversion, and 
compulsivity); and the adolescent version of the 
Personality Inventory for DSM-5 (60), which has 
recently been validated for use in adolescents (61) 
and which includes 220 items that are rated on a 
four-point Likert scale and structured into 25 
empirically derived lower-level trait pathology facets 
that assess the traits associated with DSM-5 Section 
III. 
 
Laboratory Studies 
Robins and Guze’s second principle calls for 
laboratory studies that aim to identify 
neurobiological and physiological substrates of the 
disorder. Although most laboratory studies of 
biological substrates of BPD have been conducted 
with adults, there has been a steady increase in 
biologically based studies involving adolescents. For 
example, laboratory studies of adolescent BPD have 
examined hypothalamic–pituitary–adrenal axis 
abnormalities. Kaess and colleagues (62), and 
Garner and colleagues (63) demonstrated that 
patients with BPD who were exposed to childhood 
trauma had smaller pituitaries (–18%) as compared 
with those with no history of childhood trauma. 
Consistent with clinical consensus on BPD, these 
studies suggest that the hypersecretion of cortisol 
may be associated with maladaptive stress responses 
in the development of BPD, especially in the 
presence of trauma history. 
Structural functional neuroimaging studies in 
adolescents have demonstrated volume reduction in 
the frontolimbic network, including the 
orbitofrontal cortex (OFC), and the anterior 
cingulate cortex (ACC). For example, Whittle and 
colleagues (64) reported decreased left ACC volume 
in 15 female adolescents with BPD with a wide 
range of Axis I comorbidities, and Goodman and 
colleagues (65) found that adolescents with BPD 
and comorbid major depressive disorder (MDD) 
had reduced Brodmann Area (BA) 24 gray matter 
volume as compared with healthy controls, but no 
differences were found in the size of the prefrontal 
cortex. In contrast, Brunner and colleagues (66) 
compared 20 adolescent girls with DSM-IV 
diagnoses of BPD, 20 patients with DSM-IV 
defined current psychiatric disorders, and 20 healthy 
control subjects. The findings suggested that 
adolescent clinical control subjects displayed 
significantly decreased gray matter volume in the 
right dorsolateral prefrontal cortex as compared 
with healthy control subjects, but no significant gray 
matter differences were detected between the BPD 
group and the clinical control group. Similarly, no 
group differences were found in the limbic system 
or in any white matter structures. This study 
suggests that early morphological changes in BPD 
are located in the PFC but that these changes may 
not be specific to BPD, because changes were 
similar to those found in the clinical control group. 
Finally, Chanen and colleagues (67) compared 20 
first-presentation BPD patients and 20 healthy 
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control participants and found a reversal of the 
normal (right > left) asymmetry of orbitofrontal 
gray matter volume in the BPD group, which 
reflects right-sided orbitofrontal gray matter loss in 
the BPD group as compared with control 
participants. No significant differences were found 
for amygdala or hippocampus volumes. The authors 
suggested that hippocampus and amygdala volume 
reductions observed in adult BPD samples may 
develop during the course of the disorder through 
early adulthood, but they acknowledged that 
longitudinal studies are needed to evaluate this 
further. 
Although studies of the biological substrates of 
BPD are important, most etiological theories of 
BPD favor a stress diathesis approach, which argues 
for an interaction between biological and 
environmental vulnerabilities in the development of 
BPD. This approach is also consistent with a 
developmental psychopathology framework (68). 
When considering the biological underpinnings of 
BPD and using an attachment- and mentalization-
based theoretical framework for BPD (69,70), we 
have begun to explore the mentalizing deficits that 
may underlie interpersonal dysfunction associated 
with BPD in adolescents. According to this 
theoretical approach, failures or impairments in 
mentalizing may account for the core features of 
BPD. The term mentalizing refers to our ability to 
interpret the behavior of others and ourselves in 
terms of mental states—that is, to treat ourselves 
and others as psychological agents with thoughts, 
feelings, desires, and so on (71). For optimal 
mentalizing capacity to develop, the child’s 
attachment relationships play an important role, and 
disruptions of early attachment experiences can 
derail social-cognitive development, thereby leading 
to BPD (72). In this model, emergent mentalizing 
capacity is the result of both biological and genetic 
factors (inherited theory of mind capacity and 
sensitive temperament) and environmental factors 
(adverse or mismatched family environment). A 
recent meta-analysis of functional brain imaging 
studies of theory of mind (73) identified the 
existence of a “core network” for mentalizing, 
including the medial prefrontal cortex (mPFC) and 
the bilateral posterior temporal parietal junction 
(TPJ). Although work in our laboratory has yet to 
incorporate the biological level of explanation into 
study designs, we have begun examining 
mentalizing correlates of BPD in adolescents at the 
behavioral phenotypic level. 
For instance, we used the Movie for Assessment 
of Social Cognition (MASC;74) in a sample of 132 
inpatient adolescents (Mage =15.5; 62% girls; 23% 
meeting criteria for BPD;75) to assess mentalizing 
capacity. During the administration of this tool, 
research subjects watch a 15-minute movie of four 
characters interacting around interpersonally and 
emotionally salient topics. The movie is paused 
multiple times, and research subjects are asked to 
reflect on the thoughts and feelings of the movie 
characters. Four mutually exclusive mentalizing 
styles are provided: no mentalizing (no reference is 
made to mental states to understand or explain 
characters’ behavior), undermentalizing (some 
reference is made to mental states, but it falls short 
of fully capturing the nuance of the interpersonal 
situation), hypermentalizing (mental states are over-
attributed, and inferences are based on little or no 
existing evidence), and accurate mentalizing. Results 
demonstrated that, of all four mentalizing styles, 
only hypermentalizing was associated with 
borderline traits; this behavior also distinguished 
subjects who met criteria for BPD from those who 
did not. 
In a follow-up study, we measured hyper-
mentalizing at discharge in a larger sample of 
adolescents from the same inpatient unit. Here, we 
demonstrated a significant reduction in hyper-
mentalizing, which was associated with a significant 
reduction in borderline traits (76). Importantly, in 
this study we assessed other forms of mentalizing at 
admission and discharge as well, given the fact that 
mentalizing is a multifaceted construct. These forms 
of mentalizing included explicit mentalizing through 
an emotion recognition task, empathy, and 
pseudomentalizing. Only pseudomentalizing 
showed similar associations with borderline 
symptom reduction, although these associations 
were not as significant as those associated with 
hypermentalizing. That both hypermentalizing and 
pseudomentalizing were sensitive to treatment 
effects was not surprising, because both 
hypermentalizing and pseudomentalizing are 
considered to be indices of what Fonagy and Luyten 
(77) consider to be the “pretend mode” in 
mentalization theory. Pretend mode is a form of 
impaired mentalizing in which thoughts and feelings 
become severed from reality. Pseudomentalizing in 
particular involves the use of mental states that 
appear to be rooted in reality but that, on closer 
examination, are found to be suspended from it. 
 
Summary 
Although the above studies were important to 
establish the initial empirical evidence for 
mentalizing impairment associated with BPD in the 
specific form of hypermentalizing, they are far from 
establishing the biological basis of adolescent BPD 
from the perspective of mentalizing capacity. For 
this to occur, the biological level of explanation 
must be integrated into mentalization-based studies 
of adolescent BPD in the form of, for instance, 
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neuroimaging. Such studies have been conducted in 
adults (e.g.,78), and they demonstrate the potential 
of the mentalizing construct to serve as a 
laboratory-assessed biological correlate of BPD. 
Other potential targets for laboratory studies in the 
Robins and Guze framework include reward 
function (79) and emotion dysregulation (80). Of all 
the Robins and Guze principles, the need for 
laboratory studies to establish the neurobiological 
substrates of a disorder is perhaps most strongly 
compatible with the RDoC, which we will return to 
later in this review. 
 
Delimitation from Other Disorders 
A particular challenge for the validity of BPD has 
been its high comorbidity with other disorders. 
Earlier, we discussed how the BPD criteria have 
been factor analyzed with other PDs in an attempt 
to demonstrate that BPD is a discrete disorder. 
These studies were conducted due to the high 
comorbidity between BPD and other PDs, but they 
did not replicate the DSM-based 10-factor structure 
for PD. Adult BPD demonstrates equally high 
comorbidity with both internalizing and 
externalizing disorders (81-88), and adolescent 
studies have found similar patterns of comorbidity 
(89-91). These high rates of comorbidity suggest 
that underlying structures may account for observed 
comorbidity (covariance) among disorders (47). 
James and Taylor (48) found that BPD served as a 
multidimensional indicator of both the externalizing 
dimension and the anxious-misery (distress) 
subfactor of the internalizing dimension across both 
genders. Using more rigorous assessment tools and 
a larger and more diverse sample, Eaton and 
colleagues (47) replicated this finding, again in both 
genders. We recently attempted to replicate these 
findings in a sample of 434 adolescent inpatients. 
With the use of a confirmatory factor analytic 
approach, we found support for the notion that 
adolescent BPD is a confluence of internalizing and 
externalizing pathology (92). Broadly speaking, our 
findings replicated those of both Eaton and 
colleagues (47) and James and Taylor (48): 
adolescent BPD loaded onto both internalizing and 
externalizing dimensions, and this finding was 
robust across both genders while retaining unique 
variance in the model. In other words, complete 
overlap with internalizing and externalizing 
disorders did not occur. 
 
Summary 
That BPD appears to be a confluence of 
internalizing and externalizing disorders (47), 
despite retaining unique variance, challenges the 
notion that BPD can be successfully delimited from 
other disorders. These findings point to the value of 
taking a dimensional approach to psychopathology 
in general and personality pathology in particular, 
because this allows for the cross-loading of 
components of disorder onto common latent 
factors. Therefore, in contrast with a categorical 
approach that requires the demonstration of BPD 
as a discrete disorder, the dimensional approach can 
describe how features of BPD may be shared with 
other clinical syndromes and personality pathology. 
We have begun to explore such models in the field 
of adolescent BPD, and much work is still to be 
done. However, it is becoming clear that the Robins 
and Guze requirement of discrete categorical 
diagnostic entities may not reflect the reality of 
psychopathology. 
 
Follow-Up Studies 
Robins and Guze’s fourth principle suggests that 
studies should be conducted that demonstrate a 
prototypical course and outcome of the symptoms. 
Although there is an urgent need for prospective 
studies of BPD, research conducted by other 
groups provides evidence for a prototypical course 
and outcome of adolescent BPD symptoms. For 
example, research has pinpointed the age of 13 
years as a typical age of onset for BPD (93). 
Although it is true that adolescence is characterized 
by a high prevalence of all psychiatric disorders (94), 
adolescence appears to be a particularly vulnerable 
period for BPD, hence the urgent calls from 
research for early intervention (41). As with all 
psychiatric disorders, an early onset of BPD usually 
denotes poorer outcomes (95). With its onset during 
adolescence, BPD then typically peaks during early 
adulthood and subsequently declines (96). 
Moreover, research has suggested a heterotypic 
developmental course for BPD; this involves 
coherence with regard to the underlying 
organization or meaning of behaviors over time (as 
opposed to homotypic continuity, where coherence 
is evident at the level of the behavioral phenotype 
[97]). Specifically, it appears that externalizing 
features are most strongly manifested early during 
the course of BPD (98), with internalizing features 
becoming more prominent throughout adulthood 
(47). Similar to the course of adult BPD, stability 
appears to be moderate with adolescent BPD (99-
101). 
 
Summary 
Although research is sparse, preliminary evidence is 
strong for Robins and Guze’s fourth criteria for the 
validity of psychiatric disorder. Research has 
demonstrated the comparable stability of BPD 
among adolescents, which has also been 
demonstrated for adults (99), as well as a typical 
course, which involves symptoms appearing during 
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adolescence, peaking during early adulthood, and 
then declining (96). 
 
Family Studies 
Robins and Guze’s fifth principle states that family 
studies must identify a genetic basis for the 
biological phenomena associated with the disorder. 
Several genetic studies have been conducted for 
BPD in adults, and these studies have demonstrated 
moderate heritability (96). Distel and colleagues 
(102) estimated a heritability of .42 in an adult twin 
design, and heritability rates of .69 (103) and .60 
(104) were demonstrated in other studies. Recently, 
two studies have been conducted involving 
adolescents. The first study (105) made use of a 
longitudinal birth cohort sample of 1116 pairs of 
same-sex twins who were assessed from the ages of 
5 to 12 years. The study aimed to demonstrate the 
consistency of the cause of borderline personality–
related characteristics (BPRCs) in children with 
theoretical models of the causes of adult BPD. 
Results demonstrated that, at the age of 12 years, 
mother-reported BPRCs were correlated at 0.66 
among monozygotic twins and at 0.29 among 
dizygotic twins, with findings pointing to genetic 
factors accounting for 66% of the variance in 
BPRCs. In addition, children categorized as 
belonging to an “extreme borderline group” (i.e., 
having more BPRCs) at the age of 12 years were the 
same children who, at the age of 5 years, had 
significantly lower levels of intelligence, self-control, 
and theory of mind and higher levels of impulsivity, 
externalizing, and internalizing problems. These 
children also had high rates of co-occurring conduct 
disorder, depression, anxiety, and psychosis. Finally, 
consistent with a diathesis-stress model, exposure to 
harsh treatment in the family environment (e.g., 
physical maltreatment, maternal negative expressed 
emotion) through the age of 10 years predicted 
BPRCs as well as categorization in the “extreme 
borderline” group at the age of 12 years. This 
finding suggested that environmental mediation was 
stronger among children with a family history of 
psychiatric illness. Taken together, this study 
provides important evidence for a genetic basis of 
borderline-related traits. Perhaps more importantly, 
it provides evidence for the interaction between 
genetic and environmental influences on the 
emergence of borderline-related traits in youth, a 
finding that is consistent with etiological models of 
adult BPD. 
In the second study (106), the longitudinal course 
and heritability of BPD traits were examined over a 
10-year period beginning at the age of 14 years and 
ending at the age of 24 years using a twin design. 
Mean-level BPD traits were found to decline 
significantly from adolescence to adulthood, but 
rank order stability remained high. BPD traits were 
moderately heritable at all ages, with a slight trend 
toward increased heritability from the age of 14 
years to the age of 24 years. 
Although several candidate genes have been 
implicated for adult BPD (e.g., tryptophan 
hydroxylase [107], 5HT2a [108], 5HT2c [109], 
monoamine oxidase [110]), thus far, only one study 
has examined genetic polymorphisms associated 
with adolescent BPD. In a replication of findings 
from adults with BPD, an association between 5-
HTTLPR and BPD traits in children and 
adolescents between the ages of 9 and 15 years were 
demonstrated; carriers of the short allele of 5-
HTTLPR exhibited the highest levels of BPD traits 
(111). 
 
Summary 
Since 1970, when Robins and Guze published their 
article calling for a systematic approach to 
establishing the validity of psychiatric disorder, 
research in the fields of behavioral and molecular 
genetics and the neurosciences have been 
revolutionized. At that time, one-to-one relations 
between genotypes and psychiatric phenotypes were 
thought possible, and gene–environment 
interactions in psychiatric disorders may have been 
considered but certainly not modeled. Today, we 
know that, for most psychiatric disorders (including 
BPD), evidence supports a view that constitutional 
factors (e.g., temperament) and environmental 
factors (e.g., family factors) both have etiological 
roles. For example, in an innovative recent study 
using a twin design (112), the temperamental traits 
of behavioral disinhibition or externalizing (EXT; 
impulsivity and inability to inhibit undesirable 
actions) and negative emotionality or internalizing 
(INT; predisposition to experience depression, 
anger, and anxiety) in interaction with child abuse 
(CA) to predict borderline traits over time was 
investigated. Three causal models were tested: a 
direct causal model (CA  BPD), a diathesis stress 
model (INT/EXT x CA  BPD), and a genetic 
mediation model where the CA–BPD association 
was better accounted for by common genetic risk 
factors (i.e., INT, EXT, or additive INT and EXT 
psychopathology could account for genetic or 
environmental influences common to CA and 
BPD). The authors found the strongest support for 
a genetic mediation model in which the association 
between exposure to traumatic events and BPD 
may be better accounted for by common genetic 
influences rather than the former causally 
influencing the latter. 
More studies of gene/biology–environment 
interactions are now needed. There is also an urgent 
need for studies that consider more than one 
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biological level of explanation simultaneously. The 
limitations of the Robins and Guze approach are 
clear, and we can now turn our attention to the 
NIMH’s answer to these limitations. 
 
National Institute of Mental Health Research 
Domain Criteria 
In the above review of the Robins and Guze 
criteria, we have shown that the construct of 
adolescent BPD meets some of these criteria. For 
example, there is some evidence for the 
unidimensional factor structure of adolescent BPD 
(although we acknowledge that this evidence was 
found at a low threshold), and there is some 
evidence for neurobiological correlates that are 
specific to adolescent BPD. We have also discussed 
research that demonstrates a meaningful course for 
the disorder during adolescence. However, the 
discussion of the Robins and Guze criteria has also 
revealed limitations of the construct validity of 
adolescent BPD. These limitations may be due to 
the fact that BPD is an invalid construct during 
adolescence. However, limitations may also be the 
result of the possibility that the Robins and Guze 
criteria are not an appropriate yardstick for 
evaluating the validity of psychiatric disorders. It is 
in this context that we now turn to an alternative 
approach to developing and evaluating the 
construct validity of psychiatric disorders. 
The NIMH developed the RDoC in response to 
long-held criticisms of the DSM system of 
validating psychiatric disorder, which, as we 
discussed, was informed by the Robins and Guze 
criteria. In contrast with this system, the RDoC 
does not subscribe to a categorical system but rather 
propagates a dimensional system that spans the 
range from typical to atypical behavior. In addition, 
although the DSM system of diagnostic criteria was 
by and large determined by consensus (15), the 
RDoC are agnostic with regard to DSM categories. 
Instead, the RDoC seeks to generate classifications 
from basic behavioral neuroscience. Whereas the 
Robins and Guze system sought to find the 
neurobiological substrates for DSM diagnosis, the 
RDoC’s starting point is knowledge of behavior–
brain relations that can then be linked to clinical 
phenomena; this is typically based on dimensional 
ratings that cut across different psychiatric disorders 
(17). To this end, the RDoC provides a matrix with 
rows that cover five domains of function: negative 
valence systems, positive valence systems 
(approach/motivation), cognitive systems, systems 
for social processes, and arousal/regulatory systems. 
Each of the domains is associated with relevant 
constructs selected for the potential that a particular 
brain circuit or area could reasonably be specified to 
implement that dimension of behavior. For example 
(and of most relevance to the laboratory studies 
described previously), the RDoC systems for social 
processes include the following constructs: 
imitation, theory of mind (mentalizing), social 
dominance, facial expression, identification, 
attachment/separation fear, and self-representation. 
The columns of the matrix represent seven different 
units of analysis: genes, molecules, cells, neural 
circuits, physiology, behaviors, and self-report. The 
idea is that researchers would study these constructs 
across psychiatric disorders and make use of latent 
trait analyses to “carve nature more closely at its 
joints.”This is done in the hope that we would 
develop over time a more valid nosology of 
psychiatric disorder. 
To our knowledge, the RDoC has not yet been 
applied to either adult or adolescent BPD. We 
believe, however, that the RDoC system holds 
promise for further evaluating and establishing the 
validity of BPD during adolescence. 
 
Future Research Directions 
In this article, we have presented some of the 
research that we have conducted in our own 
laboratory as well as the research conducted by 
others to evaluate the validity of BPD in 
adolescents. Like most research in psychiatry, our 
work has been guided by the influential Robins and 
Guze criteria for the validity of psychiatric disorder. 
As discussed, the limitations of this approach are 
now well acknowledged, and the question arises as 
to how we can advance knowledge regarding the 
validity of adolescent BPD within the new NIMH 
RDoC framework. A natural first step is to abandon 
studies that recruit subjects based on the inclusion 
criterion of a BPD diagnosis. Instead, large cohorts 
of patients and non-patients who represent a broad 
spectrum of psychiatric diagnoses should be 
recruited. Like recent studies that make use of latent 
trait approaches to locate BPD within the 
internalizing/externalizing spectrum (47,48,92) or to 
evaluate BPD in the context of other PDs (113), 
studies of adolescent BPD must recruit across the 
full spectrum of typical/atypical behavior. Measures 
that assess the behavioral phenotype must then be 
used alongside biological measures and preferably 
across multiple levels (e.g., genes, molecules, cells, 
neural circuits, physiology). Multivariate statistics 
can then be employed to find patterns of 
covariation among variables. Latent class analyses 
can also be employed if a more person-centered 
approach is preferred. This enterprise is risky not 
only for BPD but also for other psychiatric 
disorders, because findings may challenge our long-
held implicit belief system, which guides everyday 
clinical decision making. Alternatively, to better 
understand and effectively treat psychiatric illness, 
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we must be willing to flexibly expand on the 
foundational work that has been conducted during 
the past 40 years. Making the decision to embark on 
this endeavor may in time leave us pleasantly 
surprised. 
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